Company news
Forte Biosciences, Inc. news in 2025
Forte Biosciences, Inc.'s news releases, calls and decks from 2025, newest first.
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
December 22, 2025
Forte Biosciences, Inc. Announces Third Quarter 2025 Results and Provides Update
November 14, 2025
Forte Biosciences Inc. Reports Inducement Grants Under Nasdaq Listing Rules
October 6, 2025
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
October 3, 2025
Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium
September 15, 2025
Forte Biosciences, Inc. Announces Results and Provides Update
August 14, 2025
Forte Biosciences Announces Pricing of $75 Million Public Offering
June 25, 2025
Forte Biosciences Announces Proposed Public Offering
June 24, 2025
Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study
June 23, 2025
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
March 31, 2025